MiRXES
Developer of a diagnostic test platform designed to detect cancer at an asymptomatic stage. The company specializes in providing clinical diagnostic tools that seek to recognize early cancer detection in clinical examinations with its microRNA quantification test, enabling healthcare professionals to identify cancer at early stages.